Single/JJ
and/CC
Dual/JJ
Ligand/NN
Effects/NNS
on/IN
Gene/NN
Expression/NN
Changes/NNS
in/IN
Mouse/NN
Macrophage/NN
Cells/NNS
./.
====================
We/PRP
identified/VBD
differentially/RB
expressed/VBN
genes/NNS
in/IN
RAW/NN
264.7/CD
====================
cells/NNS
in/IN
response/NN
to/TO
single/JJ
and/CC
double/JJ
ligand/NN
treatments/NNS
(/(
LPS/NN
,/,
IFNy/JJ
,/,
2MA/NN
,/,
LPS/NN
plus/CC
IFNy/NN
,/,
and/CC
LPS/NN
plus/CC
2MA/NN
)/)
./.
====================
The/DT
majority/NN
of/IN
the/DT
regulated/VBN
transcripts/NNS
responded/VBD
additively/RB
to/TO
dual/JJ
ligand/NN
treatment/NN
./.
====================
However/RB
,/,
a/DT
significant/JJ
fraction/NN
responded/VBD
in/IN
a/DT
non-additive/JJ
fashion/NN
./.
====================
Several/JJ
cytokines/NNS
showing/VBG
non-additive/JJ
transcriptional/JJ
responses/NNS
to/TO
dual/JJ
ligand/NN
treatment/NN
also/RB
showed/VBD
non-additive/JJ
protein/NN
production/secretion/NN
responses/NNS
in/IN
separately/RB
performed/VBN
experiments/NNS
./.
====================
Many/JJ
of/IN
the/DT
genes/NNS
with/IN
non-additive/JJ
responses/NNS
to/TO
LPS/NN
plus/CC
2MA/NN
showed/VBD
enhanced/VBN
responses/NNS
and/CC
encoded/VBN
pro-inflammatory/JJ
proteins/NNS
./.
====================
LPS/NN
plus/CC
IFNy/NN
appeared/VBD
to/TO
induce/VB
both/CC
non-additive/JJ
enhancement/NN
and/CC
non-additive/JJ
attenuation/NN
of/IN
gene/NN
expression/NN
./.
====================
The/DT
affected/VBN
genes/NNS
were/VBD
associated/VBN
with/IN
a/DT
variety/NN
of/IN
biological/JJ
functions/NNS
./.
====================
These/DT
experiments/NNS
reveal/VBP
both/CC
dependent/JJ
and/CC
independent/JJ
regulatory/JJ
pathways/NNS
and/CC
point/NN
out/RP
the/DT
specific/JJ
nature/NN
of/IN
the/DT
regulatory/JJ
interactions/NNS
./.
====================
Toll-like/JJ
receptors/NNS
(/(
TLRs/NNS
)/)
recognize/VBP
distinct/JJ
pathogen-/NN
associated/VBN
molecular/JJ
patterns/NNS
(/(
PAMPs/NNS
)/)
,/,
such/JJ
as/IN
lipopolysaccharides/NNS
(/(
LPS/NN
)/)
of/IN
Gram-negative/JJ
bacteria/NNS
(/(
Akira/NN
et/FW
al./FW
,/,
2006/CD
)/)
./.
====================
Binding/NN
of/IN
PAMPs/NNS
to/TO
TLRs/NNS
triggers/VBZ
a/DT
complicated/JJ
series/NN
of/IN
events/NNS
leading/VBG
to/TO
increased/VBN
expression/NN
of/IN
proinflammatory/JJ
genes/NNS
./.
====================
To/TO
date/NN
,/,
10/CD
human/JJ
and/CC
13/CD
murine/JJ
proteins/NNS
related/JJ
to/TO
the/DT
Drosophila/NN
Toll/NN
have/VBP
been/VBN
characterized/VBN
(/(
Kawai/NN
and/CC
Akira/NN
,/,
2006/CD
)/)
./.
====================
For/IN
example/NN
,/,
TLR2/NN
is/VBZ
essential/JJ
for/IN
the/DT
signaling/NN
of/IN
a/DT
variety/NN
of/IN
====================
ligands/NNS
,/,
such/JJ
as/IN
peptidoglycan/NN
,/,
a/DT
main/JJ
wall/NN
component/NN
of/IN
Gram-positive/JJ
bacteria/NNS
,/,
lipopeptides/NNS
and/CC
lipoproteins/NNS
(/(
Takeuchi/NNP
etal./FW
,/,
2000/CD
)/)
./.
====================
TLR2/NN
cooperates/VBZ
with/IN
other/JJ
TLR/NN
family/NN
members/NNS
,/,
TLR1/NN
and/CC
TLR6/NN
,/,
to/TO
discriminate/VB
among/IN
different/JJ
microbial/JJ
components/NNS
./.
====================
TLR3/NN
mediates/VBZ
the/DT
response/NN
to/TO
double-stranded/JJ
viral/JJ
RNA/NN
(/(
Alexopoulou/NNP
et/FW
al./FW
,/,
2001/CD
)/)
./.
====================
TLR4/NN
is/VBZ
considered/VBN
to/TO
be/VB
the/DT
critical/JJ
component/NN
of/IN
the/DT
LPS/NN
receptor/NN
complex/NN
(/(
Hayashi/NNP
et/FW
al./FW
,/,
2001/CD
;/:
Hoshino/NN
et/FW
al./FW
,/,
1999/CD
;/:
Poltorak/NN
etal./FW
,/,
1998/CD
)/)
./.
====================
TLR5/NN
binds/VBZ
bacterial/JJ
flagellin/NN
from/IN
both/CC
Gram-positive/JJ
and/CC
GramÂ­/NN
negative/JJ
bacteria/NNS
(/(
Hayashi/NN
et/FW
al./FW
,/,
2001/CD
)/)
./.
====================
TLR9/NN
binds/VBZ
unmethylated/JJ
cytosine-guanosine/NN
(/(
CpG/NN
)/)
dinucleotide/NN
,/,
a/DT
sequence/NN
typifying/VBG
bacterial/JJ
and/CC
viral/JJ
DNA/NN
(/(
Hemmi/NN
etal./FW
,/,
2000/CD
)/)
./.
====================
Depending/VBG
on/IN
the/DT
type/NN
of/IN
cell/NN
,/,
TLR/NN
activation/NN
could/MD
lead/VB
to/TO
a/DT
variety/NN
of/IN
activities/NNS
,/,
such/JJ
as/IN
antigen-presenting/JJ
cell/NN
activation/NN
,/,
dendritic/JJ
cell/NN
maturation/NN
and/CC
B/NN
cell/NN
activation/NN
./.
====================
LPS/NN
is/VBZ
the/DT
major/JJ
constitute/VBP
of/IN
the/DT
outer/NN
membrane/NN
of/IN
Gram-negative/JJ
bacteria/NNS
./.
====================
In/IN
blood/NN
,/,
LPS/NN
forms/VBZ
a/DT
complex/NN
with/IN
serum/NN
protein/NN
LBP/NN
(/(
LPS-binding/JJ
protein/NN
)/)
./.
====================
LPS/NN
binds/VBZ
cell/NN
surface/NN
receptor/NN
CD14/NN
to/TO
enhance/VB
TLR4-dependent/JJ
LPS/NN
recognition/NN
./.
====================
After/IN
TLR4/NN
forms/NNS
a/DT
complex/NN
with/IN
protein/NN
MD-2/NN
,/,
the/DT
complex/NN
is/VBZ
transported/VBN
to/TO
the/DT
cell/NN
surface/NN
(/(
Akira/NN
etal./FW
,/,
2001/CD
;/:
Takeda/NN
etal./FW
,/,
2003/CD
;/:
Yamamoto/NN
etal./FW
,/,
2003/CD
)/)
./.
====================
TLR4/NN
is/VBZ
a/DT
membrane/NN
protein/NN
with/IN
an/DT
extracellular/JJ
leucine-rich/JJ
repeat/NN
domain/NN
and/CC
a/DT
cytoplasmic/JJ
TIR/NN
(/(
Toll-like//JJ
interleukin-1/NN
receptor/NN
)/)
domain/NN
./.
====================
In/IN
addition/NN
to/TO
LPS/NN
,/,
TLR4/NN
recognizes/VBZ
several/JJ
other/JJ
ligands/NNS
including/VBG
Taxol/JJ
and/CC
HSPs/NNS
(/(
heat/NN
shock/NN
proteins/NNS
)/)
./.
====================
TLR4/NN
activates/VBZ
two/CD
downstream/JJ
pathways/NNS
,/,
MyD88-/JJ
dependent/JJ
pathway/NN
and/CC
MyD88-independent/JJ
pathway/NN
,/,
each/DT
of/IN
which/WDT
is/VBZ
thought/VBN
to/TO
directly/RB
activate/VB
NF/NN
k/NN
B/NN
./.
====================
The/DT
MyD88-dependent/JJ
pathway/NN
recruits/VBZ
the/DT
kinases/NNS
,/,
interleukin-1/NN
receptor-associated/JJ
kinase/NN
1/CD
(/(
IRAKI/NN
)/)
and/CC
IRAK4/NN
,/,
which/WDT
phosphorylate/VBP
TNF/NN
receptor-associated/JJ
factor/NN
6/CD
(/(
TRAF6/NN
)/)
,/,
leading/VBG
to/TO
the/DT
activation/NN
of/IN
the/DT
IKK/NN
complex/NN
./.
====================
The/DT
MyD88-independent/JJ
pathway/NN
is/VBZ
dependent/JJ
on/IN
the/DT
TIR/NN
domain-containing/JJ
adaptor/NN
inducing/VBG
interferon-/NN
p/NN
(/(
Trif/NNP
)/)
adaptor/NN
molecule/NN
and/CC
Trif-related/JJ
adaptor/NN
molecule/NN
(/(
Tram/NN
)/)
./.
====================
However/RB
,/,
the/DT
genes/NNS
regulated/VBN
by/IN
TLR4/NN
activation/NN
are/VBP
not/RB
fully/RB
understood/VBN
./.
====================
In/IN
an/DT
attempt/NN
to/TO
characterize/VB
how/WRB
TLR4-mediated/JJ
signal/NN
transduction/NN
can/MD
be/VB
activated/VBN
by/IN
LPS/NN
,/,
we/PRP
applied/VBD
LPS/NN
in/IN
the/DT
murine/JJ
macrophage-like/JJ
cell/NN
line/NN
RAW/NN
264.7/CD
for/IN
a/DT
series/NN
of/IN
time/NN
points/NNS
./.
====================
In/IN
addition/NN
,/,
to/TO
determine/VB
whether/IN
simultaneous/JJ
stimulation/NN
with/IN
two/CD
ligands/NNS
had/VBD
non-additive/JJ
effects/NNS
on/IN
gene/NN
expression/NN
in/IN
RAW/NN
cells/NNS
,/,
====================
three/CD
ligands/NNS
[/(
LPS/NN
,/,
IFNy/JJ
and/CC
2MA/NN
(/(
2-methyl-thio-ATP/NN
)/)
]/)
which/WDT
activate/VBP
distinct/JJ
proximal/JJ
signaling/NN
pathways/NNS
were/VBD
used/VBN
alone/RB
or/CC
in/IN
combination/NN
as/IN
dual/JJ
ligands/NNS
(/(
LPS/NN
plus/CC
2MA/NN
and/CC
LPS/NN
plus/CC
IFNy/JJ
)/)
./.
====================
Gene/NN
expression/NN
changes/NNS
at/IN
multiple/JJ
time/NN
points/NNS
relative/JJ
to/TO
the/DT
time-matched/JJ
media/NNS
control/NN
were/VBD
determined/VBN
using/VBG
homemade/JJ
16K/NN
oligonucleotide/NN
microarrays/NNS
./.
====================
RAW/NN
264.7/CD
cells/NNS
were/VBD
treated/VBN
with/IN
LPS/NN
(/(
Sigma-/NN
Aldrich/JJ
)/)
,/,
IFNy/JJ
(/(
R/NN
&/CC
D/NN
Systems/NNS
)/)
,/,
2MA/NN
(/(
Sigma-Aldrich/JJ
)/)
,/,
LPS/NN
plus/CC
IFN/NN
y/RB
,/,
and/CC
LPS/NN
plus/CC
2MAfor/IN
up/IN
to/TO
4/CD
h./RB
Cells/NNS
were/VBD
collected/VBN
at/IN
multiple/JJ
time/NN
points/NNS
and/CC
RNAs/NNS
were/VBD
extracted/VBN
./.
====================
The/DT
same/JJ
experiment/NN
was/VBD
repeated/VBN
three/CD
times/NNS
./.
====================
RNA/NN
samples/NNS
collected/JJ
at/IN
each/DT
replicate/VBP
experiment/NN
were/VBD
processed/VBN
for/IN
microarray/NN
hybridization/NN
as/IN
described/VBN
in/IN
Zhu/NNP
et/FW
al/JJ
./.
====================
(/(
Zhu/NNP
et/FW
al./FW
,/,
2004/CD
)/)
./.
====================
The/DT
expression/NN
changes/NNS
in/IN
each/DT
treated/VBN
RNA/NN
sample/NN
were/VBD
measured/VBN
with/IN
two/CD
oligonucleotide/JJ
chips/NNS
using/VBG
the/DT
dye-swap/NN
design/NN
./.
====================
Fig/NN
./.
====================
1/CD
contains/VBZ
further/RBR
details/VBZ
of/IN
the/DT
experimental/JJ
design/NN
./.
====================
The/DT
arrays/NNS
were/VBD
scanned/VBN
using/VBG
Agilent/JJ
Scanner/NN
G2505A/NN
(/(
Agilent/JJ
Technologies/NNS
)/)
./.
====================
The/DT
image/NN
files/NNS
were/VBD
extracted/VBN
====================
with/IN
background-subtraction/NN
(/(
the/DT
Local/JJ
background/NN
subtraction/NN
method/NN
)/)
and/CC
dye-normalization/NN
(/(
the/DT
Rank/NN
====================
consistent/JJ
filter/NN
and/CC
the/DT
LOWESS/NN
algorithm/NN
)/)
using/VBG
the/DT
Agilent/JJ
G2566AA/NN
Extraction/NN
Software/JJ
Version/NN
A.6.1.1/NN
./.
====================
Log/NN
2/CD
(/(
Cy5/Cy3/NN
)/)
readouts/VBZ
from/IN
each/DT
array/NN
were/VBD
first/JJ
filtered/JJ
====================
by/IN
several/JJ
criteria/NNS
to/TO
mainly/RB
remove/VBP
unreliable/JJ
array/NN
spots/NNS
./.
====================
For/IN
features/NNS
that/DT
were/VBD
control/JJ
,/,
saturated/JJ
(/(
with/IN
``/NN
glsSaturated/JJ
''/CD
and/CC
``/NN
rlsSaturated/JJ
''/CD
flags/NNS
)/)
,/,
non-uniform/JJ
(/(
with/IN
``/NN
glsFeatNonUnifOL/NN
''/CD
and/CC
``/NN
rlsFeatNonUnifOL/NN
''/CD
flags/NNS
)/)
,/,
or/CC
below/IN
background/NN
(/(
with/IN
``/NN
glsWellAboveBG/NN
''/CD
and/CC
====================
``/CD
rlsWellAboveBG/NN
''/CD
flags/NNS
)/)
,/,
their/PRP$
log/NN
2/CD
(/(
Cy5/Cy3/NN
)/)
value/NN
was/VBD
====================
set/NN
to/TO
blank/VB
./.
====================
Additional/JJ
filters/NNS
were/VBD
applied/VBN
to/TO
eliminate/VB
====================
inconsistent/JJ
measurements/NNS
./.
====================
The/DT
average/JJ
log/NN
2/CD
(/(
treated//NN
====================
media/NNS
)/)
of/IN
the/DT
pair/NN
of/IN
dye-swap/NN
measurements/NNS
of/IN
a/DT
feature/NN
was/VBD
set/NN
to/TO
blank/VB
if/IN
one/CD
of/IN
the/DT
measurements/NNS
was/VBD
blank/JJ
./.
====================
Further/RB
,/,
the/DT
average/NN
log/NN
2/CD
(/(
treated/media/NN
)/)
of/IN
the/DT
triplicate/NN
====================
measurements/NNS
of/IN
a/DT
feature/NN
was/VBD
set/NN
to/TO
blank/VB
if/IN
more/RBR
than/IN
one/CD
of/IN
the/DT
measurements/NNS
were/VBD
blank/JJ
./.
====================
We/PRP
limited/VBD
our/PRP$
analysis/NN
to/TO
genes/NNS
whose/WP$
expression/NN
====================
significantly/RB
changed/VBD
in/IN
response/NN
to/TO
at/IN
least/JJS
one/CD
of/IN
the/DT
treatments/NNS
./.
====================
We/PRP
have/VBP
identified/VBN
differentially/RB
expressed/VBN
genes/NNS
using/VBG
B/NN
statistics/NNS
generated/VBN
by/IN
the/DT
Limma/NN
package/NN
(/(
http/NN
:/:
//bioinf.wehi.edu.au/limma//JJ
)/)
(/(
Smyth/NN
,/,
2004/CD
and/CC
2005/CD
)/)
./.
====================
Briefly/RB
,/,
the/DT
B/NN
statistics/NNS
is/VBZ
the/DT
log/NN
odds/NNS
of/IN
differential/JJ
expression/NN
[/(
logw/JJ
(/(
p1/p2/NN
)/)
,/,
where/WRB
p1/NN
is/VBZ
the/DT
probability/NN
that/DT
the/DT
two/CD
populations/NNS
are/VBP
different/JJ
and/CC
p2/NN
is/VBZ
the/DT
probability/NN
that/DT
the/DT
two/CD
populations/NNS
are/VBP
the/DT
same/JJ
]/)
./.
====================
The/DT
B/NN
statistics/NNS
has/VBZ
been/VBN
adjusted/VBN
for/IN
multiple/JJ
tests/NNS
in/IN
Limma/NN
package/NN
./.
====================
The/DT
greater/JJR
B/NN
statistics/NNS
====================
a/DT
gene/NN
has/VBZ
,/,
the/DT
greater/JJR
chance/NN
a/DT
gene/NN
of/IN
differential/JJ
====================
expression/NN
./.
====================
In/IN
general/JJ
,/,
B/NN
increases/VBZ
with/IN
log/NN
2/CD
(/(
treated//NN
control/NN
)/)
./.
====================
I/NN
n/NN
the/DT
current/JJ
analysis/NN
,/,
features/NNS
with/IN
B/NN
>/JJR
2/CD
and/CC
with/IN
an/DT
average/NN
====================
of/IN
log/NN
2/CD
(/(
treated/control/NN
)/)
>/JJR
0.75/CD
(/(
fold-change/NN
of/IN
1.7/CD
)/)
are/VBP
====================
considered/VBN
differentially/RB
expressed/VBN
./.
====================
As/IN
shown/VBN
in/IN
Fig/NN
./.
====================
2/CD
,/,
single/JJ
ligand/NN
treatment/NN
with/IN
LPS/NN
and/CC
====================
IFNy/RB
for/IN
up/RB
to/TO
4/CD
h/NN
induced/VBN
increasing/VBG
numbers/NNS
of/IN
gene/NN
expression/NN
changes/NNS
,/,
with/IN
approximately/RB
twice/RB
as/IN
many/JJ
significant/JJ
changes/NNS
in/IN
LPS/NN
responses/NNS
./.
====================
2MA/NN
induced/VBD
a/DT
similar/JJ
number/NN
of/IN
changes/NNS
as/IN
IFNy/JJ
at/IN
1/CD
h/NN
and/CC
the/DT
number/NN
of/IN
differentially/RB
expressed/VBN
features/NNS
appeared/VBD
to/TO
decrease/VB
with/IN
time/NN
./.
====================
Greater/NN
numbers/NNS
of/IN
differentially/RB
expressed/VBN
genes/NNS
were/VBD
found/VBN
in/IN
response/NN
to/TO
LPS/NN
plus/CC
IFNy/JJ
or/CC
LPS/NN
plus/CC
2MA/NN
than/IN
those/DT
found/VBN
in/IN
single/JJ
ligand/NN
responses/NNS
,/,
and/CC
this/DT
may/MD
be/VB
attributable/JJ
to/TO
both/CC
additive/JJ
and/CC
non-additive/JJ
effects/NNS
of/IN
the/DT
two/CD
single/JJ
ligands/NNS
./.
====================
Before/IN
we/PRP
proceeded/VBD
to/TO
determine/VB
the/DT
non-additive/JJ
effect/NN
on/IN
gene/NN
expression/NN
of/IN
dual/JJ
ligand/NN
treatment/NN
,/,
we/PRP
====================
characterized/VBN
gene/NN
expression/NN
changes/NNS
in/IN
single/JJ
ligand/NN
responses/NNS
./.
====================
This/DT
will/MD
allow/VB
us/PRP
(/(
a/DT
)/)
to/TO
validate/VB
previously/RB
reported/VBD
expression/NN
changes/NNS
induced/VBN
by/IN
the/DT
single/JJ
ligands/NNS
,/,
and/CC
(/(
b/LS
)/)
to/TO
identify/VB
potential/JJ
novel/JJ
target/NN
genes/NNS
of/IN
====================
specific/JJ
signaling/NN
pathways/NNS
if/IN
the/DT
genes/NNS
co-cluster/JJR
with/IN
well-characterized/JJ
known/VBN
targets/NNS
./.
====================
Information/NN
of/IN
the/DT
latter/JJ
kind/NN
can/MD
be/VB
useful/JJ
in/IN
identifying/VBG
pathway/NN
interaction/NN
mechanisms/NNS
if/IN
some/DT
of/IN
the/DT
novel/JJ
targets/NNS
are/VBP
affected/VBN
non-additively/RB
by/IN
dual/JJ
ligand/NN
treatments/NNS
./.
====================
We/PRP
used/VBD
hierarchical/JJ
clustering/NN
to/TO
characterize/VB
patterns/NNS
of/IN
gene/NN
expression/NN
changes/NNS
./.
====================
Clustering/NN
was/VBD
done/VBN
across/IN
the/DT
features/NNS
with/IN
experimental/JJ
conditions/NNS
aligned/VBD
according/VBG
to/TO
the/DT
order/NN
of/IN
time/NN
points/NNS
./.
====================
Euclidean/JJ
correlation/NN
coefficient/JJ
and/CC
complete/JJ
linkage/NN
were/VBD
used/VBN
as/IN
similarity/NN
metrics/NNS
./.
====================
The/DT
hierarchical/JJ
clustering/NN
program/NN
used/VBN
is/VBZ
implemented/VBN
in/IN
the/DT
Multiple/JJ
Experiment/JJ
Viewer/JJR
(/(
http/NN
:/:
//www.tigr.org/software/tm4/mev.html/NN
)/)
./.
====================
Single/JJ
ligand/NN
treatment/NN
with/IN
LPS/NN
,/,
IFNy/JJ
,/,
and/CC
2MA/NN
all/DT
induced/VBD
strong/JJ
expression/NN
changes/NNS
as/IN
early/JJ
as/IN
1/CD
h/NN
(/(
Fig/NN
./.
====================
3/CD
)/)
./.
====================
As/IN
shown/VBN
in/IN
Fig/NN
./.
====================
3/CD
,/,
additional/JJ
expression/NN
changes/NNS
were/VBD
induced/VBN
at/IN
2/CD
h/NN
and/CC
4/CD
h/NN
in/IN
LPS/NN
and/CC
IFNy/JJ
responses/NNS
,/,
and/CC
many/JJ
2MA-/NN
induced/VBD
changes/NNS
were/VBD
transient/JJ
and/CC
subsided/VBD
with/IN
time/NN
./.
====================
A/DT
number/NN
of/IN
the/DT
known/JJ
LPS-/NN
or/CC
IFNy-/JJ
regulated/VBN
genes/NNS
showed/VBD
expected/VBN
expression/NN
changes/NNS
in/IN
our/PRP$
experiment/NN
./.
====================
As/IN
shown/VBN
in/IN
Fig/NN
./.
====================
4A/DT
,/,
known/VBN
direct/JJ
target/NN
genes/NNS
of/IN
the/DT
MyD88-NFi/NN
</JJR
B/NN
pathway/NN
activated/VBN
by/IN
LPS/NN
through/IN
the/DT
TLR4/NN
,/,
such/JJ
as/IN
TNFa/NN
,/,
IL1J3/NN
and/CC
Mail/NN
,/,
were/VBD
strongly/RB
induced/VBN
at/IN
0.5/CD
h/NN
,/,
while/IN
Csf2/NN
,/,
Csf3/NNP
,/,
IL6/NN
and/CC
Cebpb/NN
,/,
the/DT
known/JJ
transcription/NN
targets/NNS
of/IN
Mail/NN
,/,
were/VBD
induced/VBN
later/RB
at/IN
1/CD
h/NN
or2/CC
h/NN
(/(
Kawai/NNP
,/,
2001/CD
;/:
Yamamoto/RB
et/FW
al./FW
,/,
2004/CD
)/)
./.
====================
Similarly/RB
,/,
known/VBN
primary/JJ
target/NN
genes/NNS
of/IN
another/DT
pathway/NN
activated/VBN
by/IN
LPS/NN
,/,
the/DT
Myd88-independent/JJ
IRF3/NN
pathway/NN
,/,
such/JJ
as/IN
Irg1/NNP
,/,
IP-10/NN
,/,
Rantes/NNS
,/,
Ifitl/NNP
,/,
Ifnb/NNP
and/CC
Isg15/NN
,/,
were/VBD
induced/VBN
at/IN
0.5/CD
h/NN
or/CC
1/CD
h/NN
,/,
while/IN
Mx1/NN
and/CC
Irf7/NNP
,/,
genes/NNS
induced/VBN
by/IN
secreted/VBN
Ifnb/NN
,/,
were/VBD
up/RB
regulated/VBN
later/RB
by/IN
LPS/NN
at/IN
2/CD
h/NN
and/CC
4/CD
h/NN
,/,
respectively/RB
(/(
Fig/NN
./.
====================
4B/NN
)/)
(/(
Doyle/NN
et/FW
al./FW
,/,
2002/CD
;/:
Hoshino/NN
et/FW
====================
al./FW
,/,
2002/CD
)/)
./.
====================
As/IN
shown/VBN
in/IN
Fig/NN
./.
====================
4C/NN
,/,
several/JJ
reported/VBN
IFNy/RB
-induced/JJ
immediate/JJ
early/JJ
genes/NNS
regulated/VBN
by/IN
the/DT
STAT/NN
1/CD
pathway/NN
,/,
such/JJ
as/IN
Irf/RB
1/CD
,/,
Icsbpl/NN
,/,
Stat2/NN
,/,
IP-10/NN
and/CC
Ifitl/JJ
,/,
also/RB
increased/VBD
their/PRP$
expression/NN
significantly/RB
at/IN
1/CD
h/NN
[/(
reviewed/VBD
in/IN
(/(
Boehm/NNP
et/FW
al./FW
,/,
1997/CD
)/)
]/)
./.
====================
We/PRP
also/RB
found/VBD
several/JJ
known/JJ
MAPK-induced/JJ
genes/NNS
,/,
such/JJ
as/IN
Egr1/NN
,/,
Egr2/NN
,/,
and/CC
Dusp2/NN
,/,
in/IN
clusters/NNS
of/IN
early/JJ
induced/VBN
genes/NNS
by/IN
2MA/NN
(/(
Fig/NN
./.
====================
4D/CD
)/)
./.
====================
We/PRP
computed/VBD
the/DT
net/NN
expression/NN
fold-change/VBP
in/IN
response/NN
to/TO
each/DT
single/JJ
ligand/NN
and/CC
to/TO
dual/JJ
ligand/NN
treatment/NN
at/IN
each/DT
time/NN
point/NN
for/IN
each/DT
gene/NN
using/VBG
the/DT
====================
average/NN
of/IN
the/DT
triplicate/NN
log/NN
2/CD
-ratio/NN
measurements/NNS
after/IN
====================
filtering/VBG
as/IN
follows/VBZ
:/:
(/(
1/CD
)/)
Sets/NNS
that/DT
do/VBP
not/RB
have/VB
at/IN
least/JJS
two/CD
data/NNS
points/VBZ
are/VBP
not/RB
used/VBN
(/(
e.g./FW
,/,
blank/NN
,/,
blank/NN
,/,
2/CD
)/)
./.
====================
(/(
2/CD
)/)
If/IN
two/CD
of/IN
the/DT
triplicates/NNS
show/VBP
different/JJ
signs/NNS
and/CC
have/VBP
a/DT
standard/JJ
deviation/NN
above/JJ
0.5/CD
,/,
the/DT
data/NNS
is/VBZ
not/RB
used/VBN
(/(
e.g./FW
,/,
-2,2/CD
,/,
0.5/CD
)/)
./.
====================
(/(
3/CD
)/)
If/IN
one/CD
data/NNS
set/VBP
shows/VBZ
more/RBR
than/IN
a/DT
2/CD
fold/JJ
difference/NN
====================
(/(
log/NN
2/CD
ratio/NN
of/IN
1/CD
)/)
and/CC
the/DT
other/JJ
points/NNS
do/VBP
not/RB
,/,
that/DT
data/NNS
is/VBZ
not/RB
====================
used/VBN
,/,
unless/IN
the/DT
standard/JJ
deviation/NN
is/VBZ
less/RBR
than/IN
0.5/CD
./.
====================
(/(
e.g./FW
,/,
3/CD
,/,
0.2/CD
,/,
0.2/CD
)/)
(/(
4/CD
)/)
The/DT
remaining/VBG
data/NNS
points/VBZ
are/VBP
averaged/VBN
and/CC
used/VBN
in/IN
the/DT
analysis/NN
./.
====================
The/DT
difference/NN
between/IN
the/DT
fold-change/NN
induced/VBD
by/IN
dual/JJ
ligand/NN
and/CC
the/DT
sum/NN
of/IN
fold-changes/NNS
induced/VBD
by/IN
single/JJ
ligands/NNS
was/VBD
used/VBN
as/IN
a/DT
measure/JJ
of/IN
the/DT
non-additive/JJ
effect/NN
(/(
Fig/NN
./.
====================
5/CD
)/)
./.
====================
We/PRP
then/RB
added/VBN
the/DT
fold-change/NN
differences/NNS
at/IN
1/CD
h/NN
,/,
2/CD
h/NN
,/,
and/CC
4/CD
h/NN
together/RB
,/,
and/CC
used/VBN
the/DT
resulting/VBG
sum/NN
to/TO
rank/VB
genes/NNS
in/IN
descending/VBG
order/NN
./.
====================
In/IN
the/DT
current/JJ
analysis/NN
,/,
we/PRP
generally/RB
considered/VBN
genes/NNS
that/WDT
ranked/VBD
at/IN
the/DT
top/NN
(/(
the/DT
sum/NN
being/VBG
positive/JJ
)/)
as/IN
candidates/NNS
whose/WP$
expression/NN
was/VBD
enhanced/VBN
non-additively/RB
by/IN
the/DT
dual/JJ
ligands/NNS
,/,
and/CC
====================
genes/NNS
that/WDT
ranked/VBD
at/IN
the/DT
bottom/CC
(/(
the/DT
sum/NN
being/VBG
negative/JJ
)/)
as/IN
candidates/NNS
whose/WP$
expression/NN
was/VBD
attenuÂ­/RB
ated/VBD
non-additively/RB
by/IN
the/DT
dual/JJ
ligand/NN
treatments/NNS
./.
====================
Tables/NNS
1-4/CD
showed/VBD
gene/NN
expression/NN
changes/NNS
(/(
as/IN
average/JJ
Iog2-ratios/NNS
)/)
of/IN
the/DT
single/JJ
time/NN
point/NN
and/CC
the/DT
sum/NN
fold-change/NN
differences/NNS
of/IN
these/DT
top/bottom/IN
ranked/VBD
genes/NNS
in/IN
responses/NNS
to/TO
LPS/NN
+/CC
IFNy/JJ
or/CC
LPS/NN
+/CC
2MA/NN
./.
====================
Table/JJ
1/CD
listed/VBN
genes/NNS
whose/WP$
expression/NN
was/VBD
enhanced/VBN
non-/NN
additively/RB
by/IN
LPS/NN
+/CC
IFNy/JJ
./.
====================
Non-additively/RB
enhanced/VBD
genes/NNS
including/VBG
IL6/NN
and/CC
IL10/NN
were/VBD
also/RB
measured/VBN
in/IN
cytokine/NN
secretion/NN
assays/NNS
./.
====================
Secreted/VBN
IL6/NN
in/IN
response/NN
to/TO
====================
LPS/NN
+/CC
IFNy/JJ
was/VBD
clearly/RB
non-additively/RB
enhanced/VBD
at/IN
4/CD
h/NN
and/CC
a/DT
slight/JJ
non-additive/JJ
effect/NN
was/VBD
seen/VBN
in/IN
IL10/NN
production/NN
at/IN
4/CD
h/NN
(/(
data/NNS
not/RB
shown/VBN
)/)
./.
====================
Other/JJ
interesting/JJ
genes/NNS
including/VBG
Sgk/JJ
,/,
Nolal/JJ
,/,
Crabp2/NN
,/,
and/CC
Fst/JJ
did/VBD
not/RB
show/VB
significant/JJ
changes/NNS
at/IN
most/JJS
time/NN
points/NNS
in/IN
response/NN
to/TO
either/CC
LPS/NN
or/CC
IFNy/JJ
,/,
but/CC
showed/VBD
strong/JJ
changes/NNS
when/WRB
LPS/NN
and/CC
IFNy/JJ
were/VBD
applied/VBN
together/RB
./.
====================
Whether/IN
these/DT
changes/NNS
are/VBP
reflected/VBN
at/IN
the/DT
protein/NN
level/NN
,/,
what/WP
mechanisms/NNS
underlie/VBP
the/DT
changes/NNS
,/,
and/CC
the/DT
nature/NN
of/IN
the/DT
biological/JJ
significance/NN
of/IN
these/DT
changes/NNS
remain/VBP
to/TO
be/VB
seen/VBN
./.
====================
Similar/JJ
results/NNS
are/VBP
found/VBN
in/IN
Tables/NNS
2-4/CD
./.
====================
Socsl-/JJ
and/CC
Cish-mediated/JJ
feedback/NN
inhibition/NN
and/CC
PGE2/NN
(/(
prostaglandin/NN
E2/NN
)/)
negative/JJ
feedback/NN
seem/VBP
to/TO
attenuate/VB
the/DT
transcriptional/JJ
responses/NNS
to/TO
LPS/NN
plus/CC
IFN7/NN
(/(
Table/JJ
1/CD
)/)
./.
====================
The/DT
increased/VBN
number/NN
of/IN
less-than-additive/JJ
transcriptional/JJ
changes/NNS
induced/VBN
by/IN
LPS/NN
plus/CC
IFN7/NN
at/IN
4/CD
h/NN
(/(
Table/JJ
2/CD
)/)
was/VBD
preceded/VBN
by/IN
a/DT
significant/JJ
induction/NN
of/IN
Socsl/JJ
and/CC
Cish/JJ
(/(
Table/JJ
1/CD
)/)
,/,
genes/NNS
encoding/VBG
putative/JJ
inhibitors/NNS
of/IN
LPS/NN
,/,
and/CC
Ptgs2/NN
and/CC
Ptger4/NN
,/,
genesencoding/VBG
COX-2/NN
and/CC
EP4/NN
,/,
an/DT
enzyme/NN
and/CC
a/DT
receptor/NN
for/IN
the/DT
synthesis/NN
and/CC
binding/VBG
of/IN
PGE2/NN
,/,
respectively/RB
./.
====================
In/IN
response/NN
to/TO
LPS/NN
plus/CC
2MA/NN
,/,
the/DT
enhancement/JJ
of/IN
LPS-induced/JJ
expression/NN
of/IN
IFNp/JJ
at/IN
1/CD
h/NN
and/CC
2/CD
h/NN
(/(
Table/JJ
3/CD
)/)
was/VBD
followed/VBN
by/IN
the/DT
increased/VBN
expression/NN
of/IN
multiple/JJ
interferon/NN
induced/VBD
genes/NNS
,/,
such/JJ
as/IN
Gbp2/JJ
,/,
Irf1/NNP
,/,
Mx1/NNP
,/,
and/CC
Mx2/NNP
,/,
and/CC
the/DT
attenuation/NN
of/IN
LPS-induced/JJ
expression/NN
of/IN
IL10/NN
at/IN
1/CD
h/NN
and/CC
2/CD
h/NN
(/(
Table/JJ
4/CD
)/)
correlated/VBD
with/IN
the/DT
increased/VBN
expression/NN
of/IN
IL10/NN
repressed/VBD
genes/NNS
later/RB
at/IN
4/CD
h/NN
including/VBG
IL1a/NN
,/,
IL1p/JJ
,/,
IL6/NN
,/,
IL18/NN
,/,
Pim1/NN
,/,
and/CC
Socsl/JJ
./.
====================
It/PRP
can/MD
be/VB
hypothesized/VBN
that/IN
2MA-induced/JJ
Ca/NN
2+/JJ
mobilization/NN
activates/VBZ
NFAT/NN
,/,
and/CC
NFAT/NN
synergizes/VBZ
with/IN
IRF3/NN
activated/VBN
by/IN
LPS/NN
in/IN
the/DT
transcriptional/JJ
induction/NN
of/IN
IFNp/JJ
./.
====================
Consistent/JJ
with/IN
this/DT
possibility/NN
,/,
the/DT
5/CD
â/NN
upstream/RB
region/NN
of/IN
the/DT
mouse/NN
and/CC
human/JJ
IFNp/JJ
genes/NNS
have/VBP
a/DT
NFAT/NN
site/NN
,/,
an/DT
====================
IRF/NN
site/NN
overlapped/VBD
with/IN
the/DT
NFAT/NN
site/NN
,/,
and/CC
a/DT
NF/NN
k/NN
B/NN
site/NN
./.
====================
The/DT
IRF/NN
site/NN
and/CC
the/DT
NF/NN
k/NN
B/NN
site/NN
mediate/VBP
IFNp/JJ
transcriptional/JJ
activation/NN
by/IN
IRF3/NN
and/CC
NF/NN
k/NN
B/NN
in/IN
response/NN
to/TO
LPS/NN
(/(
Doyle/NN
et/FW
al./FW
,/,
2002/CD
)/)
./.
====================
In/IN
summary/NN
,/,
analysis/NN
of/IN
gene/NN
expression/NN
response/NN
to/TO
single/JJ
ligands/NNS
allowed/VBD
us/PRP
to/TO
identify/VB
expression/NN
changes/NNS
indicative/JJ
of/IN
the/DT
activation/NN
of/IN
specific/JJ
signaling/NN
pathways/NNS
(/(
Fig/NN
./.
====================
6/CD
)/)
./.
====================
While/IN
genes/NNS
showing/VBG
such/JJ
changes/NNS
include/VBP
known/VBN
target/NN
genes/NNS
of/IN
the/DT
pathway/NN
,/,
novel/JJ
target/NN
genes/NNS
were/VBD
also/RB
found/VBD
./.
====================
Computational/JJ
analysis/NN
of/IN
transcriptional/JJ
regulatory/JJ
pathways/NNS
activated/VBN
by/IN
various/JJ
ligands/NNS
,/,
such/JJ
as/IN
TLR/NN
ligands/NNS
,/,
with/IN
palpable/JJ
waves/NNS
of/IN
transcription/NN
will/MD
not/RB
only/RB
reveal/VBP
the/DT
independent/JJ
pathway/NN
of/IN
each/DT
ligand/NN
but/CC
also/RB
give/VBP
further/RB
ideas/IN
of/IN
cross/JJ
signaling/NN
networks/NNS
within/IN
or/CC
with/IN
other/JJ
signal/JJ
transduction/NN
pathways/NNS
by/IN
further/JJ
exploring/VBG
the/DT
data/NNS
./.
====================
